The ScaleiQ platform

---

Our platform transforms raw clinical and imaging data into actionable biomarkers and longitudinal insight. It operates as an end-to-end pipeline—ingesting data at scale, identifying signals others miss, and translating them into a continuous view of patient health.

At the core are advanced correlation algorithms that uncover relationships across imaging biomarkers, clinical data, and real-world evidence—revealing novel biomarkers and linking them to disease progression, treatment response, and emerging safety signals.

These signals are unified into a continuous, longitudinal view of patient health, enabling earlier detection of safety risks, more precise monitoring of systemic toxicity, and a clearer understanding of how disease and treatment evolve over time.